Literature DB >> 3804019

Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study.

O Broström, R Löfberg, A Ost, H Reichard.   

Abstract

An eight year endoscopical and histological cancer surveillance programme comprising 71 patients with ulcerative colitis is presented. Forty one patients had total colitis and 30 substantial colitis. Mean duration of the disease was 19.7 years (range 9-46 years). An average of 2.6 colonoscopies per patient in the total colitis group were carried out, and at least two biopsies were taken at 10 locations in the colon. In the total colitis group, seven had either low (four), or high grade dysplasia (two), or Dukes' A cancer (one). In the group with substantial colitis two patients with low grade dysplasia were found. Dysplasia or cancer leading to operation was found above the rectum in four of five operated patients, all having had total colitis for 25 to 44 years. The dysplasia and cancer findings at the colonoscopy preceding surgery corresponded well with the surgical specimens. In three operated patients a sequence of dysplasia development was recorded. With the exception of long duration and dysplasia, nothing in the clinical course distinguished the operated cases. Using this surveillance programme prophylactic colectomy can be limited to patients in a high risk group developing dysplasia. The risk of missing a cancer before it becomes incurable seems to be low.

Entities:  

Mesh:

Year:  1986        PMID: 3804019      PMCID: PMC1433971          DOI: 10.1136/gut.27.12.1408

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  THE CANCER RISK IN ULCERATIVE COLITIS.

Authors:  I P MACDOUGALL
Journal:  Lancet       Date:  1964-09-26       Impact factor: 79.321

2.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

3.  The development of carcinoma of the large intestine in ulcerative colitis.

Authors:  I M DAWSON; J PRYSE-DAVIES
Journal:  Br J Surg       Date:  1959-09       Impact factor: 6.939

4.  An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area.

Authors:  J G Evans; E D Acheson
Journal:  Gut       Date:  1965-08       Impact factor: 23.059

Review 5.  The precarcinomatous phase of ulcerative colitis.

Authors:  R H Riddell
Journal:  Curr Top Pathol       Date:  1976

6.  Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis.

Authors:  D L Sackett; G Whelan
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

7.  Cancer in colitis: assessment of the individual risk by clinical and histological criteria.

Authors:  J E Lennard-Jones; B C Morson; J K Ritchie; D C Shove; C B Williams
Journal:  Gastroenterology       Date:  1977-12       Impact factor: 22.682

8.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

9.  The occurrence of severe epithelial dysplasia and its bearing on treatment of longstanding ulcerative colitis.

Authors:  J Kewenter; L Hultén; C Ahrén
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

10.  Endoscopic surveillance for cancer in chronic ulcerative colitis.

Authors:  J A Fuson; R G Farmer; A Hawk; B H Sullivan
Journal:  Am J Gastroenterol       Date:  1980-02       Impact factor: 10.864

View more
  33 in total

1.  Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.

Authors:  C H Lim; M F Dixon; A Vail; D Forman; D A F Lynch; A T R Axon
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

2.  Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

Authors:  J A Eaden; J F Mayberry
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

3.  Screening for colorectal cancer in ulcerative colitis.

Authors: 
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

Review 4.  Colonoscopic surveillance in ulcerative colitis--dysplasia through the looking glass.

Authors:  J B Fozard; M F Dixon
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

5.  Letters to the editor.

Authors:  J E Lennard-Jones
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

Review 6.  How do we assess the value of surveillance techniques in ulcerative colitis?

Authors:  C N Bernstein
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

Review 7.  Use of probe-based confocal laser endomicroscopy (pCLE) in gastrointestinal applications. A consensus report based on clinical evidence.

Authors:  Kenneth K Wang; David L Carr-Locke; Satish K Singh; Helmut Neumann; Helga Bertani; Jean-Paul Galmiche; Razvan I Arsenescu; Fabrice Caillol; Kenneth J Chang; Stanislas Chaussade; Emmanuel Coron; Guido Costamagna; Aldona Dlugosz; S Ian Gan; Marc Giovannini; Frank G Gress; Oleh Haluszka; Khek Y Ho; Michel Kahaleh; Vani J Konda; Frederic Prat; Raj J Shah; Prateek Sharma; Adam Slivka; Herbert C Wolfsen; Alvin Zfass
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

8.  Diagnostic accuracy of confocal laser endomicroscopy in diagnosing dysplasia in patients affected by long-standing ulcerative colitis.

Authors:  Antonio Rispo; Fabiana Castiglione; Stefania Staibano; Dario Esposito; Francesco Maione; Maria Siano; Francesca Salvatori; Stefania Masone; Marcello Persico; Giovanni Domenico De Palma
Journal:  World J Gastrointest Endosc       Date:  2012-09-16

Review 9.  Failure of colonoscopic surveillance in ulcerative colitis.

Authors:  D A Lynch; A J Lobo; G M Sobala; M F Dixon; A T Axon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

10.  Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium.

Authors:  M Yamada; T Ohkusa; I Okayasu
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.